Activation of FGFR2 Signaling Suppresses BRCA1 and Drives Triple-Negative Mammary Tumorigenesis That is Sensitive to Immunotherapy.
Lei JH, Lee MH, Miao K, Huang Z, Yao Z, Zhang A, Xu J, Zhao M, Huang Z, Zhang X, Chen S, Jiaying NG, Feng Y, Xing F, Chen P, Sun H, Chen Q, Xiang T, Chen L, Xu X, Deng CX.
Lei JH, et al. Among authors: huang z.
Adv Sci (Weinh). 2023 Dec;10(36):e2307935. doi: 10.1002/advs.202307935.
Adv Sci (Weinh). 2023.
PMID: 38153360
Free PMC article.
No abstract available.